Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


3rd Annual Pre-Filled Syringes Summit

24 Sep 2013 - 26 Sep 2013 - Washington DC, USA



Bookmark and Share


Get clarity on regulations and learn to develop safer, more robust pre-filled syringes…
The market for pre-filled syringes continues to grow healthily, but why is the field still held back by the same issues year after year? Component quality still isn’t consistent; package integrity is still proving tough to test robustly enough. Regulations on human factors and combination products are as unclear as ever.

The 3rd Annual Pre-Filled Syringes Summit, will bring together leaders from all areas of pre-filled syringe development, manufacturing and regulation. Together we will share and discuss ideas to help overcome the problems holding back progress. So join us to help uncover and develop practical, near term, solutions to solve themNOW.

With an agenda put together with the help of thought leaders from the FDA,Genentech, Pfizer, Amgen, Eli Lilly, Baxter, Sanofi, Novartis, Janssen,Hospira, GlaxoSmithKline and many more, the 3rd Annual Pre-filled Syringes Summit will dig deeper than any other meeting. You will leave with immediately actionable solutions to help get your pre-filled syringe projects moving in the right direction. Whether you need clarity on regulations, or want an opportunity to network and discuss the problems you currently face, The 3rd Annual Pre-Filled Syringes Summit is the only North American meeting this year that can truly deliver.


Further information
Scientific News
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!